易感性和疾病修饰基因在肌缩性侧面硬化症:从遗传关联到治疗影响
Sean W Willemse1, Michael A van Es
1Department of Neurology, UMC Utrecht Brain Center Rudolf Magnus, Utrecht, The Netherlands.
Current opinion in neurology
|June 20, 2023
概括
基因向疗法正在彻底改变肌缩性侧面硬化症 (ALS) 治疗. 了解ALS遗传学的进步已经导致SOD1-ALS的第一个有效的基因疗法,有更多有前途的治疗方法正在开发中.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,其特征是运动神经元损失.
- 通过大规模的遗传研究,已经确定了60多个与ALS相关的基因,并通过大规模的遗传研究进行了功能性特征.
- 了解ALS的遗传基础对于开发有效治疗方法至关重要.
研究的目的:
- 审查近期ALS遗传发现如何转化为新的治疗策略.
- 突出针对ALS的基因向疗法的潜力.
- 讨论基因向临床试验的可行性和进展情况.
主要方法:
- 对大规模基因研究的审查,确定与ALS相关的基因.
- 分析新兴的基因向治疗技术,如反感性寡核酸治疗 (ASO).
- 检查自然历史研究的表型-基因型相关性和生物标志物发展.
主要成果:
- 反感性寡核酸治疗 (ASOs) 已经使SOD1-ALS.的第一个成功的基因治疗成为可能.
- 目前正在进行多个针对ALS的基因向临床试验.
- 包括因果突变和修饰剂在内的遗传变异被证实是可行的治疗标.
结论:
- 技术的进步有助于揭开ALS遗传学.
- 由自然史研究和生物标志物支持的基因向方法正在使ALS临床试验成为可能.
- 第一个有效的SOD1-ALS治疗方法的开发标志着一个新时代,有望出现更多的治疗方法.
相关概念视频
01:15Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611
01:28Human Genetics
628
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
628
03:03Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K